Dr. Jonathan Kolitz, MD

• Hematology

• Medical Oncology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Memorial Sloan - Kettering Cancer Center

  Fellowship Hospital

• Mem Sloan-kettering Cancer Ctr, Hematology/oncology North Shore University Hosp, Internal Medicine

  Residency Hospital

• Memorial Sloan Kettering Can Ct

  Fellowship Hospital, 1985

• North Shore University Hospital

  Internship Hospital, 1980

• Yale School Of Medicine

  Medical School, 1979

• Columbia University Vagelos College Of Physicians And Surgeons

  Undergraduate School, 1975

• Columbia University

  Undergraduate School, 1975

• English

• Spanish

• Mutations in theCCND1andCCND2genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia, 2016-11-15

• Recombinant Interleukin-2 in Patients Aged Younger Than 60 Years With Acute Myeloid Leukemia in First Complete Remission Results From Cancer and Leukemia Group B 19808, 2013-12-31

• Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia, 2017-12-12

• GAS6expression identifies high-risk adult AML patients: potential implications for therapy, 2013-12-11

• Mechanistic insights into CpG DNA and IL-15 synergy in promoting B-cell chronic lymphocytic leukemia clonal expansion, 2018-08-01

• No evidence for microsatellite instability in acute myeloid leukemia, 2017-03-24

• High Dose Cytarabine plus Gemtuzumab Ozogamicin for Patients with Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902, 2010-08-04

• The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients withde novoacute myeloid leukemia, 2017-03-24

• Prognostic and biologic significance ofDNMT3Bexpression in older patients with cytogenetically normal primary acute myeloid leukemia, 2014-09-10

• The Impact of Initial Fludarabine Therapy on Transformation to Richter's Syndrome or Prolymphocytic Leukemia in Patients with Chronic Lymphocytic Leukemia: Analysis of an Intergroup Trial (CALGB 9011), 2012-09-08

• Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells, 2022-03-15

• Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8, 2014-03-21

• Persistence ofDNMT3AR882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia, 2016-08-01

• Cytoplasmic myosin exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability, 2015-07-29

• Phase II, Multicenter, Randomized Trial of CPX-351 (cytarabine:daunorubicin) Liposome Injection versus Intensive Salvage Therapy in Adults with First Relapse AML, 2014-09-15

• Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503), 2016-09-13

• Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes, 2015-10-19

• TLR-9 and IL-15 synergy promotes thein vitroclonal expansion of chronic lymphocytic leukemia B cells, 2015-07-01

• Dose Intensification of Daunorubicin and Cytarabine during Treatment of Adult Acute Lymphoblastic Leukemia: Results of Cancer and Leukemia Group B Study 19802, 2012-06-28